URGP

 
Common Stock / Status : Suspended
OTC Pink Limited Information
Contact Info
  • 1990 North California Blvd
  • Suite 830
  • Walnut Creek, CA 94596


Update Company Info
Business Description

Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for urological disorders. Urigen's lead program targets significant unmet medical need and major market opportunities in urology. Urigen's URG101, a proprietary combination of approved drugs that is instilled into the bladder, targets interstitial cystitis / bladder pain syndrome , which affects approximately 10.5 million men and women in North America.

 
Financial Reporting/Disclosure
Reporting Status U.S. Registered & Reporting: SEC Filer
Audited Financials Audited
Latest Report Not Available
Regulatory Agency Not Available
CIK 0000932352
Fiscal Year End 6/30
OTC Market Tier OTC Pink Limited
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers
Dan B. Vickery Secretary
Company Directors
Dan B. Vickery Chairman
C. Lowell Parsons
Edward R. Teitel
Company Notes
  • Formerly=Valentis, Inc. until 7-07
  • Formerly=Megabios Corp. until 5-99
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
URGP Security Details
Share Structure
Market Value1 $2,278,324 a/o May 23, 2012
Shares Outstanding 73,494,327 a/o Sep 22, 2009
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record 347 a/o Sep 24, 2009
Short Selling Data
Short Interest 3,034 (69.4%)
Apr 30, 2012
Significant Failures to Deliver No
Transfer Agent(s)
Computershare Investor Services LLC

1Market Value calculated only for respective security